Safety and quality of life analyses of apalutamide plus active surveillance vs active surveillance alone for low, intermediate risk prostate cancer. - Archive ouverte HAL Accéder directement au contenu
Communication Dans Un Congrès Année : 2023

Safety and quality of life analyses of apalutamide plus active surveillance vs active surveillance alone for low, intermediate risk prostate cancer.

Sebastien Crouzet
Fichier non déposé

Dates et versions

hal-04326098 , version 1 (06-12-2023)

Identifiants

Citer

Gwenaelle Gravis, Patrick Sfumato, Guillaume Ploussard, Pierre-Henri Savoie, Matthieu Durand, et al.. Safety and quality of life analyses of apalutamide plus active surveillance vs active surveillance alone for low, intermediate risk prostate cancer.. Genitourinary Cancers Symposium, Feb 2023, San Francisco, United States. ⟨10.1200/JCO.2023.41.6_suppl.352⟩. ⟨hal-04326098⟩
9 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More